The New Lung Allocation System and Its Impact on Waitlist Characteristics and Post-Transplant Outcomes

Seminars in Thoracic and Cardiovascular Surgery

Volumn 20, Issue 2, 2008, Pages 139-142

  Hachem, Ramsey R ^a   Trulock, Elbert P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

lung transplantation; organ allocation; post transplant outcomes; waitlist mortality

Indexed keywords

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; EARLY DIAGNOSIS; GRAFT DYSFUNCTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HEALTH CARE PLANNING; HOSPITAL ADMISSION; HUMAN; LUNG INSUFFICIENCY; LUNG TRANSPLANTATION; RISK BENEFIT ANALYSIS; RISK REDUCTION; SURGICAL MORTALITY; SURVIVAL TIME; TREATMENT OUTCOME; UNITED STATES;

HEALTH CARE RATIONING; HUMANS; LUNG DISEASES; LUNG TRANSPLANTATION; PATIENT SELECTION; TISSUE AND ORGAN PROCUREMENT; UNITED STATES; WAITING LISTS;

EID: 49049091187     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2008.04.004     Document Type: Article

References (19)

1. Trulock E.P., Christie J.D., Edwards L.B., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant 26 (2007) 782-795
2. Kawut S.M., Reyentovich A., Wilt J.S., et al. Outcomes of extended donor lung recipients after lung transplantation. Transplantation 79 (2005) 310-316
3. Ware L.B., Wang Y., Fang X., et al. Assessment of lungs rejected for transplantation and implications for donor selection. Lancet 360 (2002) 619-620
4. Egan T.M., Murray S., Bustami R.T., et al. Development of the new lung allocation system. Am J Transplant 6 (2006) 1212-1227
5. Barr M.L., Bourge R.C., Orens J.B., et al. Thoracic organ transplantation in the United States, 1994-2003. Am J Transplant 5 (2005) 934-949
6. Pierson R.N., Barr M.L., McCullough K.P., et al. Thoracic organ transplantation. Am J Transplant 4 suppl 9 (2004) 93-105
7. Barst R.J., Rubin L.J., Long W.A., et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 334 (1996) 296-301
8. Fuchs H.J., Borowitz D.S., Christiansen D.H., et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N Engl J Med 331 (1994) 637-642
9. Ramsey B.W., Dorkin H.L., Eisenberg J.D., et al. Efficacy of aerosolized tobramycin in patients with cystic fibrosis. N Engl J Med 328 (1993) 1740-1746
10. Hosenpud J.D., Bennett L.E., Keck B.M., et al. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 351 (1998) 24-27
11. Department of Health and Human Services. Organ Procurement and Transplantation Network. Final Rule, in Federal Register 42 CFR, part 121, October 20 (1999) 56649-56661
12. Egan T.M., Bennett L.E., Garrity E.R., et al. Predictors of death on the UNOS lung transplant waiting list: results of a multivariate analysis. J Heart Lung Transplant 20 (2001) S242-S243 (abstract)
13. Egan T.M., McCullough K., Murray S., et al. Risk factors for death after lung transplant in the US. J Heart Lung Transplant 22 (2003) S146-S147 (abstract)
14. Kerem E., Reisman J., Corey M., et al. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 326 (1992) 1187-1191
15. Liou T.G., Adler F.R., Fitzsimmons S.C., et al. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol 153 (2001) 345-352
16. Garrity E.R., Moore J., Mulligan M.S., et al. Heart and lung transplantation in the United States 1996-2005. Am J Transplant 7 (2007) 1390-1403
17. Hachem RR, Yusen RD, Meyers BF, et al: Impact of the New Lung Allocation System in the US: A Single Center Study. Proceedings of the Twenty-Seventh Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation, San Francisco, California, April 25-28, 2007
18. Kozower B.D., Meyers B.F., Smith M.A., et al. The impact of the lung allocation score on short-term transplantation outcomes: a multicenter study. J Thorac Cardiovasc Surg 135 (2008) 166-171
19. McCue J.D., Mooney J., Quail J., et al. Ninety-day mortality and major complications are not affected by use of lung allocation score. J Heart Lung Transplant 27 (2008) 192-196